Table 2. Unadjusted and adjusted hazard ratios of being lost to follow-up among 6,108 patients enrolled into care in LUTH HIV treatment program from January 2010-December 2014.
| Variables | Unadjusted HR (95% CI) | p-value | Adjusted HRa (95% CI) | p-value | Adjusted HRb (95% CI) (N = 3603) | p-value |
|---|---|---|---|---|---|---|
| Age (per 10 years) | 0.99(0.94–1.03) | 0.599 | 0.96(0.90–1.02) | 0.177 | 1.00(0.95–1.05) | 0.969 |
| Sex | ||||||
| Female | Ref | Ref | ||||
| Male | 1.12(1.02–1.23) | 0.020 | 1.06(0.94–1.19) | 0.343 | - | - |
| Marital status | ||||||
| Married | Ref | Ref | Ref | |||
| Single | 1.23(1.10–1.37) | <0.001 | 1.17(1.03–1.33) | 0.014 | 1.21(1.08–1.36) | 0.001 |
| Divorced/Separated/Widowed | 1.21(1.05–1.40) | 0.007 | 1.18(1.00–1.38) | 0.046 | 1.30(1.12–1.50) | <0.001 |
| Education | ||||||
| None | Ref | Ref | ||||
| Primary | 1.07(0.89–1.29) | 0.481 | 1.20(0.97–1.47) | 0.088 | - | - |
| Secondary | 0.86(0.72–1.02) | 0.083 | 0.94(0.78–1.14) | 0.523 | ||
| Tertiary | 0.81(0.68–0.97) | 0.024 | 0.89(0.72–1.08) | 0.238 | ||
| Disease progression at baseline | ||||||
| CD4≥200 and/or WHO Stage 1–2 | Ref | Ref | ||||
| CD4<200 and/or WHO Stage 3–4 | 1.29(1.17–1.43) | <0.001 | 1.30(1.16–1.45) | <0.001 | - | - |
| Year of enrollment | ||||||
| 2010 | Ref | Ref | ||||
| 2011 | 1.09(0.96–1.23) | 0.192 | 3.15(2.74–3.61) | <0.001 | - | - |
| 2012 | 1.11(0.97–1.27) | 0.122 | 1.04(0.89–1.20) | 0.625 | ||
| 2013 | 1.24(1.07–1.43) | 0.004 | 0.88(0.71–1.08) | 0.222 | ||
| 2014 | 1.26(1.06–1.51) | 0.009 | 1.21(0.99–1.48) | 0.061 |
HR: Hazards Ratio Ref: Reference category
aFull cox’s proportional hazard model
bFinal cox’s proportional hazard model (Schoenfeld Residuals Test p = 0.062)